We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNY
76
Bank of New York Mellon
BNY
$106B
$45M 0.29%
780,731
-26,033
-3% -$1.43M
ABBV icon
77
AbbVie
ABBV
$465B
$44.5M 0.28%
244,486
+23,834
+11% +$4.11M
APD icon
78
Air Products & Chemicals
APD
$65.2B
$44.3M 0.28%
182,766
-35,836
-16% -$8.78M
NEE icon
79
NextEra Energy
NEE
$186B
$43.8M 0.28%
684,785
-146,771
-18% -$8.6M
NBIX icon
80
Neurocrine Biosciences
NBIX
$18.4B
$43.5M 0.28%
315,684
-54,215
-15% -$7.4M
JNJ icon
81
Johnson & Johnson
JNJ
$643B
$43.3M 0.28%
273,499
-33,731
-11% -$5.37M
KROS icon
82
Keros Therapeutics
KROS
$199M
$43.2M 0.28%
651,999
-167,063
-20% -$9.91M
AWK icon
83
American Water Works
AWK
$27B
$42.9M 0.27%
351,390
-115,296
-25% -$14.2M
MCD icon
84
McDonald's
MCD
$194B
$42.7M 0.27%
151,621
-47,221
-24% -$13.7M
PGR icon
85
Progressive
PGR
$128B
$42.3M 0.27%
204,708
+58,128
+40% +$10.8M
ELV icon
86
Elevance Health
ELV
$83.7B
$41.1M 0.26%
79,355
+29,267
+58% +$14.6M
TJX icon
87
TJX Companies
TJX
$178B
$41M 0.26%
403,790
-407,981
-50% -$39.6M
SLB icon
88
SLB Ltd
SLB
$74.2B
$40.7M 0.26%
742,968
+70,483
+10% +$3.55M
INTC icon
89
Intel
INTC
$435B
$40.7M 0.26%
921,793
+299,091
+48% +$13.3M
VIPS icon
90
Vipshop
VIPS
$7.13B
$40.6M 0.26%
2,109,751
-1,121,600
-35% -$18.9M
EL icon
91
Estee Lauder
EL
$30.7B
$40.2M 0.26%
260,784
+106,630
+69% +$15.1M
BMY icon
92
Bristol-Myers Squibb
BMY
$130B
$39.6M 0.25%
730,126
+131,449
+22% +$6.7M
IONS icon
93
Ionis Pharmaceuticals
IONS
$9.14B
$39.5M 0.25%
911,897
+282,830
+45% +$13.5M
CTAS icon
94
Cintas
CTAS
$86B
$38.9M 0.25%
226,216
+30,716
+16% +$4.73M
ADP icon
95
Automatic Data Processing
ADP
$106B
$38.3M 0.25%
153,429
-72,547
-32% -$17.7M
MDLZ icon
96
Mondelez International
MDLZ
$80.2B
$37.6M 0.24%
537,288
-51,088
-9% -$3.73M
ALTR
97
DELISTED
Altair Engineering Inc
ALTR
$37.5M 0.24%
+434,749
New +$36.9M
PH icon
98
Parker-Hannifin
PH
$125B
$37.1M 0.24%
66,789
-849
-1% -$431K
SNPS icon
99
Synopsys
SNPS
$73.5B
$37.1M 0.24%
64,880
-22,798
-26% -$12.5M
PFE icon
100
Pfizer
PFE
$144B
$36.3M 0.23%
1,308,162
+426,371
+48% +$11.8M
2 3
4
5 6

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.